Sg Americas Securities, LLC Nymox Pharmaceutical Corp Transaction History

Sg Americas Securities, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 09, 2020	SELL	$2.3 - $3.66 $48,962 - $77,914	-21,288 Closed	0 $0
Q2 2020 Jul 20, 2020	BUY	$2.1 - $4.6 $44,704 - $97,924	21,288 New	21,288 $76,000
Q1 2019 Apr 29, 2019	SELL	$1.57 - $2.71 $20,932 - $36,132	-13,333 Closed	0 $0
Q4 2018 Feb 01, 2019	BUY	$1.31 - $2.53 $17,466 - $33,732	13,333 New	13,333 $17,000

150K

Ticker NYMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,265,000
Market Cap $42.9M
Description
Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population in Canada, the United States, Europe, and internationally. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which has completed Phase III clinical trials for the treatment of benign prostatic hyperpl...

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg Americas Securities, LLC with notifications on news.